Victory Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-328,228
Closed -$1.57M 2845
2021
Q4
$1.57M Sell
328,228
-14,880
-4% -$96K ﹤0.01% 1648
2021
Q3
$2.6M Sell
343,108
-3,070
-0.9% -$19.6K ﹤0.01% 1506
2021
Q2
$2.58M Sell
346,178
-21,810
-6% -$168K ﹤0.01% 1563
2021
Q1
$2.87M Sell
367,988
-8,480
-2% -$84.8K ﹤0.01% 1535
2020
Q4
$3.48M Sell
376,468
-65,980
-15% -$573K ﹤0.01% 1339
2020
Q3
$3.05M Sell
442,448
-159,010
-26% -$965K ﹤0.01% 1309
2020
Q2
$3.95M Sell
601,458
-745,690
-55% -$2.69M 0.01% 1221
2020
Q1
$2.52M Buy
1,347,148
+861,998
+178% +$2.27M ﹤0.01% 1506
2019
Q4
$912K Sell
485,150
-91,531
-16% -$152K ﹤0.01% 1780
2019
Q3
$819K Buy
576,681
+85,931
+18% +$188K ﹤0.01% 1738
2019
Q2
$1.38M Sell
490,750
-33,550
-6% -$134K ﹤0.01% 1232
2019
Q1
$2.5M Sell
524,300
-5,280
-1% -$26K 0.01% 1043
2018
Q4
$2.25M Sell
529,580
-9,220
-2% -$71.2K 0.01% 1011
2018
Q3
$5.89M Sell
538,800
-29,160
-5% -$342K 0.01% 830
2018
Q2
$9.26M Buy
+567,960
New +$8.22M 0.02% 769

Other funds holding SURF

Victory Capital Management's SURF Position: Q1 2022 in Review

Victory Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2022, closing a stake of 328,228 shares — an estimated $1.57M sold.

Victory Capital Management first reported a position in SURF in Q2 2018 and held it in 15 quarters. The position peaked at $9.26M in Q2 2018. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

  • Victory Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 328,228 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $1.57M.
  • Victory Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 15 quarters.
  • Victory Capital Management's Surface Oncology, Inc. Common Stock position peaked at $9.26M in Q2 2018.
  • 103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.